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Abstract
Endoscopic resection (ER) of undifferentiated-type early 
gastric cancer (UD-EGC) has a lower curative resection 
(CR) rate than does ER of differentiated-type EGC 
(D-EGC). However, a low CR rate does not mean that it 
is unreasonable to schedule ER of UD-EGC. If ER is in 
fact curative, the long-term outcomes including survival 
rate are excellent. Quality of life is good because 
maximal stomach preservation is possible. However, 
UD-EGC and D-EGC differ histologically. Thus, when ER 
is contemplated to treat UD-EGC, a careful approach 
employing strict criteria is essential because the biology 
of UD-EGC and D-EGC differ.
Key words: Early gastric cancer; Undifferentiated; Endo-
scopic resection; Lymph node metastasis
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Core tip: If endoscopic resection (ER) of undiffer-
entiated-type early gastric cancer (UD-EGC) is in 
fact curative, the long-term outcomes are excellent. 
However, when ER is contemplated to treat UD-EGC, 
a careful approach employing strict criteria is essential 
because the biology of UD-EGC and differentiated-type 
EGC (D-EGC) differ. In this review, we will discuss the 
important points to perform ER in UD-EGC according to 
the data known so far.
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INTRODUCTION
Traditionally, the standard treatment for early gastric 
cancer (EGC) is surgery. However, more recently, 
endoscopic resection (ER) has become a standard local 
treatment for some patients with EGC who lack lymph 
node metastasis (LNM)[1]. Initially, ER was used to 
treat differentiated-type EGC (D-EGC) with a < 2-cm-
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diameter tumor confined to the mucosa[2-4]. Today, the 
indications for ER have been expanded in many studies 
to even include undifferentiated-type EGC (UD-EGC) 
with ≤ 2-cm-diameter without either ulceration or 
lymphovascular invasion[5]. Such indications are used 
to decide on both the feasibility before and curability 
after ER. If curability is considered doubtful, additional 
surgery should be performed. Many studies have 
explored the feasibility and effectiveness of ER to treat 
UD-EGC[6-10]. 
However, gastric cancers exhibiting undifferentiated-
type histology exhibit biological behaviors differing from 
those of D-EGC. The former cancers are characterized 
by higher frequencies of both LNM and infiltrative 
growth[11]. Thus, any decision to employ ER of UD-
EGC must be very carefully made. The present review 
emphasizes the points that must be considered.
HIsTOlOgICal DIagNOsIs Of UD-EgC 
pRIOR TO ER
Histological diagnosis prior to treatment is important, 
especially if ER is contemplated. Furthermore, a 
change from D-EGC status on prior biopsy to UD-EGC 
status at the time of ER is critical in terms of a decision 
to perform additional surgery after ER and to predict 
prognosis[12]. In previous studies, about 15% to 18% 
of patients with UD-EGC diagnosed after ER exhibited 
differentiated histology on biopsy prior to ER[12,13]. A 
tumor diameter of > 2 cm and bodily location predict 
the histological features of UD-EGC[12-14]. A UD-EGC 
exhibiting differentiated histology on earlier biopsy is 
more aggressive and associated with a lower curative 
resection rate than is a UD-EGC, consistent with the 
biopsy pathologies[12-14]. When precise histological 
diagnosis prior to ER is required, magnifying endo-
scopy (ME) with narrow-band imaging (NBI) is 
helpful. Additionally, the actual biopsy site may be 
more important than the number of biopsies taken. A 
previous study featuring histopathological mapping and 
evaluation of the endoscopic appearance of UD-EGCs 
that exhibited differentiated histology on prior biopsy 
found that the zone of transition from differentiated to 
undifferentiated-type histology frequently occurred in 
one or two peripheral regions of the lesion[12]. Thus, 
biopsy of several peripheral regions may aid in the 
diagnosis of undifferentiated-type histology prior to 
ER[12].
UNDIffERENTIaTED-TypE HIsTOlOgy 
aND ER Of EgCs
The risk of LNM is the most important factor to 
consider when contemplating ER of EGCs[7]. Thus, 
the indications for ER are the absence of risk factors 
associated with LNM and include consideration of 
the histological status of the EGC. The relevant 
histological classifications include those of the World 
Health Organization (WHO), Lauren, and Japanese 
experts[1,7,15,16]. Many studies have found that the 
biological behaviors of EGC vary according to his-
tological differentiations[17,18].
ER has been performed with reference to the 
Japanese classification, which simply categorizes 
patients with EGC into those with differentiated or 
undifferentiated-type histology. In this classification, 
undifferentiated adenocarcinoma[19] is a cancer 
that lacks glands and includes poorly differentiated 
adenocarcinoma (PDA), signet ring cell carcinoma 
(SRC), and mucinous adenocarcinoma (MA) (as does 
the WHO system). PDA and MA are associated with 
higher LNM rates than are EGCs of other histological 
types, and the SRC form of EGC is associated 
with relatively less LNM than are EGCs of other 
histologies[20-23]. Thus, biological behaviors such as 
LNM differ among the histopathological subtypes of 
UD-EGC. 
However, when ER is performed with reference to 
current indications, the clinical outcomes of PDA and 
SRC patients do not differ significantly[6,10]. The first 
report on the use of ER to treat UD-EGCs of various 
histological subtypes found no instance of either local 
recurrence or distant metastasis in patients with either 
PDA or SRC if curative resection (CR) was attained[10]. 
This result was validated on long-term follow-up (Figure 
1)[6]. Therefore, the current criteria for CR of UD-EGC 
can be applied to both patients with PDA and those 
with SRC, who enjoy good long-term outcomes.
The current indications for ER do not include 
EGC of mixed histology. As mentioned above, the 
Japanese classification categorizes EGCs into only 
gastric cancers of differentiated or undifferentiated-
type histology. However, many studies have found that 
EGCs of mixed histologies exhibit more aggressive 
clinicopathological behaviors than do EGCs of non-
mixed histologies[18,24-26]. We also found that SRC mixed 
histology, defined as an adenocarcinoma with a minor 
component less than 50% of the SRC, is associated 
with more LNM than are EGCs of other histologies[18]. 
We therefore explored the clinicopathological behaviors 
of EGCs of mixed histology to determine whether 
new ER criteria are required (manuscript submitted). 
We measured LNM rates by all recognized types of 
mixed histology as follows: (1) the mixed type as non-
homogenous mixtures of the Lauren classification; (2) 
the mixed type of the Lauren classification divided into 
the differentiated dominant and the undifferentiated 
dominant mixed types[24]; and (3) SRC mixed histology 
identified in our previous study[18]. As found previously, 
the LNM rates were higher in patients with EGC with all 
types of mixed histology than in those with pure types 
of EGC. When analyzing within the current ER criteria, 
however, LNM was not observed. Thus, this need for 
new criteria when ER is contemplated for patients 
with EGCs of mixed histologies has not been identified 
until now. Further studies are required. Two prior 
works reported different outcomes after ER of EGCs of 
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Recur 1 
(16.7%)
ER 209
PDA 82 (39.2%) SRC 127 (60.8%)
CR 37 
(45.1%)
Non-CR 45 
(54.9%)
CR 78 
(61.4%)
Non-CR 49 
(38.6%)
Metachronous 2
(5.1%)
No 10
(22.2%)
Op 34
(75.6%)
ER 1 
(50.0%)
Op 1
(50.0%)
Recur 3
(30.0%)
Op 2
(67%)
CTx 1 
(33%)
Expire 1 Expire 1
Metachronous 3 
(3.8%)
ER 2 (4.1%)
APC 7 (14.3%)
both 3 (6.1%)
No 6
(12.2%)
Op 31
(63.3%)
ER 2
(67%)
Op 1
(33%)
Expire 1
Op 1
(8.3%)
No recurrence
APC 1
(2.2%)
Recur 1 
(2.9%)
CTx 1 
(100%)
Figure 1  Follow-up outcomes after endoscopic resection of undifferentiated-type early gastric cancer. The numbers in the boxes are the numbers of cases. 
CR: Curative resection; PDA: Poorly differentiated adenocarcinoma; SRC: Signet ring cell carcinoma; APC: Argon plasma coagulation; ER: Endoscopic resection. 
Taken with permission from Surg Endosc 2014; 28: 2627-2633[6].
mixed histology[27,28]. One found a lower CR rate and 
more local recurrence after ER of EGCs of mixed than 
pure histology[27]. However, the other study reported 
favorable long-term outcomes (including the absence 
of LNM and extragastric recurrence) during follow-
up after ER of EGCs of mixed histology that met the 
curative ER criteria[28].
ER Of UNDIffERENTIaTED-TypE EgCs
If CR is attained, the long-term outcomes after ER of 
UD-EGC are favorable in terms of local recurrence, 
LNM, distant metastasis, and survival[6,29-32]. How-
ever, the CR rates have historically been low (30%-
80%)[6,10,29,30,32-34]. The principal reason why the CR 
rate differs between PDA and SRC (although the 
long-term outcomes do not)[6,10] is that non-CR is 
associated with a vertical cut-end positive status 
in patients with PDA and a lateral cut-end positive 
status in patients with SRC[6,10].
In terms of non-CR of PDA, prediction of tumor depth 
before treatment is difficult. Although pretreatment 
evaluation via endoscopic ultrasonography (EUS) may 
suggest that the lesions are confined to the mucosa, 
the lesions may in fact have attained the submucosa 
(Figure 2)[10,35]. Such observations suggest that 
pretreatment EUS evaluation of the invasion depth 
may often underestimate such depth in patients with 
PDA, consistent with data of a previous study in which 
PDA histological features were significantly associated 
with understaging of the invasion depth upon 
multivariate analysis[10,35]. Therefore, the possibility of 
depth underestimation upon EUS should be considered 
prior to ER of PDA. Strict EUS criteria for submucosal 
invasion should be established to avoid T-stage 
underestimation for achieving CR in PDA[10,35].
With respect to non-CR of SRC, it is difficult to 
define the extent of the lesion. ME with NBI has been 
used in efforts to precisely define the lateral extent 
of EGC[6,36,37]. However, several studies found that 
such predictions were inaccurate in patients with 
UD-EGC, but not in those with D-EGC[6,37,38]. Yao et 
al[38] suggested that the strategy should vary by the 
histological type of EGC (D- vs UD-EGC). For the latter 
type of tumor, the margins should be determined by 
biopsy of apparently non-cancerous tissue surrounding 
the lesion and histological confirmation of the absence 
of any cancerous invasion[38]. In other words, it is 
difficult to precisely define the lateral margins of UD-
EGCs; pathological confirmation is required. Surface 
ME with NBI will not detect any cancer-specific, 
irregular microvascular or microsurface pattern if the 
cancer cells have infiltrated the lamina propria, perhaps 
to the depth of the glandular neck[38]. The origin 
of SRC reportedly differs from that of other gastric 
adenocarcinomas[39]. Tubule neck dysplasia (TND) 
may be a precursor lesion of SRC[39]. TND can spread 
upward toward the foveolar surface and possibly 
downward to the gastric glands[39]. Thus, the gastric 
mucosal surface epithelium in patients with early-
stage SRC may appear to be largely intact despite 
the presence of cancer cells in the lamina propria. It 
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of UD-EGC and not simply to perform advanced 
endoscopy such as ME with NBI. Again, UD-EGC differs 
from D-EGC[6]. 
Undifferentiated histology is the principal risk 
factor for the presence of residual tumor cells after 
complete resection of EGC[44]. PDA, SRC, and a 
minimum lateral safety margin of < 3 mm are 
significantly associated with residual tumors[44]. Short-
term endoscopic follow-up with close examination 
of the resected base may reveal a residual tumor 
although CR of UD-EGC is histologically evident[44].
A negative lateral margin (i.e., a margin free of 
cancerous cells) is very important in the context of CR. 
However, no consensus has emerged on the extent of 
this margin. A lateral margin of > 3 mm may increase 
the success rate of CR[44]. Further studies of patients 
with PDA and SRC are required.
Figure 5 showed a suggested decision algorithm for 
ER of UD-EGC.
aDDITIvE TREaTmENT afTER NON-CR 
Of UD-EgC
The poorer CR rates of UD-EGC[6,10,29,30,32-34] than D-EGC 
suggest that additive treatments may be required 
after ER. Residual cancer cells and LNM were evident 
may be useful to define ER subgroups of SRC based 
on intramucosal spreading patterns such as epithelial 
spread, and not simply to determine resection margins 
via endoscopy or biopsy. Indeed, we examined the 
intramucosal spreading patterns of the SRC type of 
EGC reported previously, and identified (for example) 
both expanding (epithelial spread) and infiltrative 
(subepithelial spread) subtypes[11]. The proportion 
of infiltrative spread was higher in lateral cut-end-
positive than -negative early-stage SRCs (Figures 3 
and 4)[40]. We also found that the surrounding mucosal 
pattern was useful to define the type of intramucosal 
spread in early-stage SRCs (Figures 3 and 4)[40]. The 
mucosa surrounding infiltrative lesions more commonly 
exhibited atrophy and intestinal metaplasia[40], indicating 
that the mucosa may be an important mechanical 
barrier to tumor spread in patients with early-stage 
SRC[40]. This is in line with the fact that diagnosis of 
the extent of an undifferentiated-type lesion against 
a background of severe mucosal atrophy is quite 
difficult, even with ME/NBI[41-43]. Therefore, larger 
ER safety margins may be necessary if early-stage 
SRCs are surrounded by mucosa exhibiting atrophy 
or/and intestinal metaplasia, which often spreads sub-
epithelially to the margins[40].
Thus, to be curatively resected by ER in UD-EGC, 
it is important to consider the biological characteristics 
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B
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Figure 2  Incorrect T staging: a case of undifferentiated-type early 
gastric cancer (EGC). A: Endoscopic image of an EGC showing a 10-mm-
diameter depressed lesion in the posterior angle of the wall; B: Endoscopic 
ultrasonographic image showing a hypoechoic mucosal mass with an intact 
submucosal layer. A surgical specimen obtained upon radical subtotal 
gastrectomy confirmed that the EGC was confined to the submucosal layer. 
Taken with permission from Gastrointest Endosc 2007; 66: 901-908[35].
B
A
Figure 3  Clinical example of signet ring cell carcinoma exhibiting 
expansive intramucosal spread. A: An endoscopic image of early gastric 
cancer (EGC) showing a depressed lesion located in the posterior wall of the 
lower body. Endoscopically, the surrounding mucosa did not exhibit atrophy or 
intestinal metaplasia; B: Pathological findings after endoscopic resection (× 40). 
SRC tumor cells were superficially exposed in a mucosal region and were well-
demarcated (arrow). Taken with permission from Gut Liver 2015; 9: 720-726[40].
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CBA
Figure 4  Clinical example of the signet ring cell carcinoma associated with infiltrative intramucosal spread. A: An endoscopic image of an EGC, showing a 
flat lesion located in the lesser curvature of the lower body (circle). Endoscopically, the surrounding mucosa exhibited atrophic gastritis; B: After endoscopic resection, 
three of the lateral margins were positive (circle); C: Pathological findings after endoscopic resection (× 40). Signet ring cell carcinoma cells exhibited subepithelial 
spread. In other words, the lesion was of the infiltrative type (circle). Taken with permission from Gut Liver 2015; 9: 720-726[40].
in surgical specimens of 50% and 13% of patients, 
respectively, when additive surgery was required 
because CR had failed[6,10,30,45]. Undifferentiated 
histology was the principal risk factor for residual tumor 
cells after histologically complete resection[44]. Thus, 
additional surgery may be appropriate after ER of UD-
EGC. Hybrid natural orifice transluminal endoscopic 
surgery may be a good option for additional treatment 
after non-CR of UD-EGC. However, further work is 
necessary.
CONClUsION
A low CR rate does not indicate that ER of UD-EGC 
Figure 5  suggested decision algorithm for endoscopic resection of undifferentiated-type early gastric cancer. 1Biopsy of several peripheral regions may aid 
in the exact diagnosis of undifferentiated-type histology prior to ER; 2Histologically minimum lateral margins should be wider than 3 mm for curative resection after 
ER; 3Even when complete resection has been achieved, short-term follow-up endoscopy to detect undifferentiated histology after ER may help to evaluate the risk 
of residual tumor development. PDA: Poorly differentiated adenocarcinoma; SRC: Signet ring cell carcinoma; EUS: Endoscopic ultrasonography; ER: Endoscopic 
resection; UD-EGC: Undifferentiated-type early gastric cancer.
UD-EGC1
PDA SRC
Equivocal Submucosal 
invasion
Mucosal 
confined
Definite submucosal 
invasion
Definite mucosal 
confined 
EUS Tumor size ≤ 20 mmulcer (-)
Endoscopic resection (ER)2,3
Combined atrophy and/or 
intestinal metaplasia 
Larger safety margin necessary 
during ER
Subtle submucosal change Definite mucosal confined
Tumor size ≤ 20 mm
ulcer (-)
Endoscopic resection (ER)2,3 Surgery
Gross appearance 
of endoscopy
Yes No
Yes
Yes
No
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should not be considered. The literature shows that 
patients who achieve CR after ER enjoy excellent 
survival outcomes. Furthermore the quality of life after 
stomach preservation is good. However, the biological 
behaviors of UD-EGC and D-EGC differ. Thus, decisions 
of ER in UD-EGC must be made very carefully, em-
ploying strict criteria based on the unique biological 
features of UD-EGC.
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